Core Laboratories (NYSE:CLB) Shares Up 5.5% – Still a Buy?

Shares of Core Laboratories Inc. (NYSE:CLB) rose 5.5% during mid-day trading on Friday . The stock traded as high as $17.50 and last traded at $17.3250. Approximately 161,435 shares were traded during trading, a decline of 59% from the average daily volume of 393,920 shares. The stock had previously closed at $16.42.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “hold (c)” rating on shares of Core Laboratories in a research note on Monday, December 29th. Four investment analysts have rated the stock with a Hold rating, According to data from MarketBeat, Core Laboratories currently has an average rating of “Hold” and a consensus price target of $12.50.

Core Laboratories Stock Up 6.2%

The business has a 50-day moving average price of $17.84 and a 200-day moving average price of $15.91. The stock has a market cap of $803.11 million, a PE ratio of 26.05, a price-to-earnings-growth ratio of 13.83 and a beta of 1.10. The company has a current ratio of 2.02, a quick ratio of 1.57 and a debt-to-equity ratio of 0.41.

Core Laboratories (NYSE:CLB) last posted its quarterly earnings data on Wednesday, February 4th. The oil and gas company reported $0.21 earnings per share for the quarter, topping analysts’ consensus estimates of $0.20 by $0.01. The company had revenue of $138.26 million during the quarter, compared to analysts’ expectations of $130.40 million. Core Laboratories had a net margin of 6.04% and a return on equity of 12.18%. The firm’s revenue for the quarter was up 7.0% on a year-over-year basis. During the same period in the prior year, the business posted $0.22 earnings per share. Core Laboratories has set its Q1 2026 guidance at 0.110-0.150 EPS. As a group, analysts forecast that Core Laboratories Inc. will post 0.96 earnings per share for the current year.

Core Laboratories Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, March 9th. Investors of record on Monday, February 16th were paid a $0.01 dividend. The ex-dividend date of this dividend was Friday, February 13th. This represents a $0.04 dividend on an annualized basis and a yield of 0.2%. Core Laboratories’s dividend payout ratio (DPR) is currently 5.97%.

Institutional Investors Weigh In On Core Laboratories

Large investors have recently bought and sold shares of the company. CWA Asset Management Group LLC purchased a new position in shares of Core Laboratories in the fourth quarter valued at approximately $9,978,000. Ariel Investments LLC increased its position in shares of Core Laboratories by 25.5% during the second quarter. Ariel Investments LLC now owns 12,976,463 shares of the oil and gas company’s stock worth $149,489,000 after purchasing an additional 2,634,438 shares in the last quarter. Gendell Jeffrey L raised its stake in Core Laboratories by 24.6% in the 2nd quarter. Gendell Jeffrey L now owns 569,471 shares of the oil and gas company’s stock valued at $6,560,000 after purchasing an additional 112,475 shares during the last quarter. Geode Capital Management LLC raised its stake in Core Laboratories by 3.0% in the 2nd quarter. Geode Capital Management LLC now owns 1,114,560 shares of the oil and gas company’s stock valued at $12,842,000 after purchasing an additional 32,934 shares during the last quarter. Finally, Pacific Ridge Capital Partners LLC purchased a new position in Core Laboratories in the 3rd quarter valued at $525,000. 97.81% of the stock is currently owned by hedge funds and other institutional investors.

Core Laboratories Company Profile

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.